BSX
Boston Scientific Corp
NYSE: BSX · HEALTHCARE · MEDICAL DEVICES
$57.61
+0.80% today
Updated 2026-04-29
Market cap
$92.25B
P/E ratio
25.97
P/S ratio
4.48x
EPS (TTM)
$2.39
Dividend yield
—
52W range
$59 – $110
Volume
15.7M
Boston Scientific Corp (BSX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.82B | $8.36B | $8.05B | $8.19B | $7.81B | $7.62B | $7.25B | $7.14B | $7.38B | $7.48B | $8.39B | $9.05B | $9.82B | $10.73B | $9.91B | $11.89B | $12.68B | $14.24B | $16.75B | $20.07B |
| Revenue growth (YoY) | — | +6.9% | -3.7% | +1.7% | -4.7% | -2.4% | -4.9% | -1.5% | +3.3% | +1.3% | +12.2% | +7.9% | +8.6% | +9.3% | -7.7% | +19.9% | +6.7% | +12.3% | +17.6% | +19.9% |
| Cost of revenue | $2.74B | $2.96B | $2.96B | $3.01B | $3.02B | $2.94B | $2.69B | $2.61B | $2.72B | $2.83B | $3.04B | $3.18B | $3.35B | $3.86B | $4.34B | $4.43B | $4.97B | $5.41B | $6.48B | $6.22B |
| Gross profit | $5.08B | $5.40B | $5.09B | $5.18B | $4.79B | $4.68B | $4.56B | $4.54B | $4.59B | $4.56B | $5.34B | $5.87B | $6.48B | $6.88B | $5.58B | $7.46B | $7.71B | $8.83B | $10.27B | $13.85B |
| Gross margin | 65.0% | 64.6% | 63.2% | 63.2% | 61.3% | 61.4% | 62.9% | 63.5% | 62.2% | 61.0% | 63.7% | 64.9% | 65.9% | 64.1% | 56.2% | 62.8% | 60.8% | 62.0% | 61.3% | 69.0% |
| R&D | $1.01B | $1.09B | $999.00M | $1.03B | $939.00M | $895.00M | $886.00M | $861.00M | $817.00M | $876.00M | $920.00M | $997.00M | $1.11B | $1.17B | $1.14B | $1.20B | $1.32B | $1.41B | $1.61B | $2.05B |
| SG&A | $2.67B | $2.91B | $2.79B | $4.85B | $2.77B | $2.66B | $2.54B | $2.67B | $2.90B | $2.87B | $3.10B | $3.29B | $3.57B | $3.94B | $3.79B | $4.36B | $4.52B | $4.97B | $5.98B | $6.89B |
| Operating income | $1.24B | $1.18B | $1.29B | $1.30B | $1.07B | $1.12B | $994.00M | $871.00M | $845.00M | $790.00M | $1.24B | $1.52B | $1.74B | $1.71B | $601.00M | $1.92B | $1.82B | $2.18B | $2.63B | $3.97B |
| Operating margin | 15.8% | 14.1% | 16.1% | 15.9% | 13.7% | 14.7% | 13.7% | 12.2% | 11.4% | 10.6% | 14.7% | 16.9% | 17.7% | 15.9% | 6.1% | 16.2% | 14.4% | 15.3% | 15.7% | 19.8% |
| EBITDA | $-2.32B | $940.00M | $-699.00M | $-108.00M | $149.00M | $1.64B | $-3.16B | $721.00M | $433.00M | $360.00M | $1.23B | $2.01B | $2.58B | $2.21B | $1.51B | $2.52B | $2.74B | $3.45B | $3.94B | $3.73B |
| EBITDA margin | -29.7% | 11.2% | -8.7% | -1.3% | 1.9% | 21.5% | -43.6% | 10.1% | 5.9% | 4.8% | 14.6% | 22.2% | 26.3% | 20.6% | 15.2% | 21.2% | 21.6% | 24.2% | 23.5% | 18.6% |
| EBIT | $-3.10B | $1.00M | $-1.56B | $-942.00M | $-667.00M | $918.00M | $-3.84B | $32.00M | $-292.00M | $-409.00M | $411.00M | $1.16B | $1.69B | $1.20B | $389.00M | $1.43B | $1.60B | $2.26B | $2.67B | — |
| Interest expense | $435.00M | $570.00M | $468.00M | $366.00M | $396.00M | $276.00M | $263.00M | $255.00M | $217.00M | $241.00M | $234.00M | $230.00M | $269.00M | $513.00M | $468.00M | $349.00M | $464.00M | $272.00M | $387.00M | $349.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.58B | $-495.00M | $-2.04B | $-1.02B | $-1.06B | $441.00M | $-4.07B | $-121.00M | $-119.00M | $-239.00M | $347.00M | $104.00M | $1.67B | $4.70B | $-82.00M | $1.04B | $698.00M | $1.59B | $1.85B | $2.89B |
| Net income growth (YoY) | — | +86.2% | -311.3% | +49.7% | -3.9% | +141.4% | -1022.4% | +97.0% | +1.7% | -100.8% | +245.2% | -70.0% | +1506.7% | +181.3% | -101.7% | +1368.3% | -32.9% | +128.2% | +16.4% | +55.7% |
| Profit margin | -45.7% | -5.9% | -25.3% | -12.5% | -13.6% | 5.8% | -56.1% | -1.7% | -1.6% | -3.2% | 4.1% | 1.1% | 17.0% | 43.8% | -0.8% | 8.7% | 5.5% | 11.2% | 11.1% | 14.4% |